(Press-News.org) Contact information: Dr. Oliver Brüstle
r.neuro@uni-bonn.de
49-228-688-5500
University of Bonn
Human stem cells predict efficacy of Alzheimer drugs
Researchers from the University of Bonn use reprogrammed patient neurons for drug testing
Why do certain Alzheimer medications work in animal models but not in clinical trials in humans? A research team from the University of Bonn and the biomedical enterprise LIFE & BRAIN GmbH has been able to show that results of established test methods with animal models and cell lines used up until now can hardly be translated to the processes in the human brain. Drug testing should therefore be conducted with human nerve cells, conclude the scientists. The results are published by Cell Press in the journal "Stem Cell Reports".
In the brains of Alzheimer patients, deposits form that consist essentially of beta-amyloid and are harmful to nerve cells. Scientists are therefore searching for pharmaceutical compounds that prevent the formation of these dangerous aggregates. In animal models, certain non-steroidal anti-inflammatory drugs (NSAIDs) were found to a reduced formation of harmful beta-amyloid variants. Yet, in subsequent clinical studies, these NSAIDs failed to elicit any beneficial effects.
"The reasons for these negative results have remained unclear for a long time", says Prof. Dr. Oliver Brüstle, Director of the Institute for Reconstructive Neurobiology of the University of Bonn and CEO of LIFE & BRAIN GmbH. "Remarkably, these compounds were never tested directly on the actual target cells – the human neuron", adds lead author Dr. Jerome Mertens of Prof. Brüstle's team, who now works at the Laboratory of Genetics in La Jolla (USA). This is because, so far, living human neurons have been extremely difficult to obtain. However, with the recent advances in stem cell research it has become possible to derive limitless numbers of brain cells from a small skin biopsy or other adult cell types.
Scientists transform skin cells into nerve cells
Now a research team from the Institute for Reconstructive Neurobiology and the Department of Neurology of the Bonn University Medical Center together with colleagues from the LIFE & BRAIN GmbH and the University of Leuven (Belgium) has obtained such nerve cells from humans. The researchers used skin cells from two patients with a familial form of Alzheimer's Disease to produce so-called induced pluripotent stem cells (iPS cells), by reprogramming the body's cells into a quasi-embryonic stage. They then transformed the resulting so-called "jack-of-all-trades cells" into nerve cells.
Using these human neurons, the scientists tested several compounds in the group of non-steroidal anti-inflammatory drugs. As control, the researchers used nerve cells they had obtained from iPS cells of donors who did not have the disease. Both in the nerve cells obtained from the Alzheimer patients and in the control cells, the NSAIDs that had previously tested positive in the animal models and cell lines typically used for drug screening had practically no effect: The values for the harmful beta-amyloid variants that form the feared aggregates in the brain remained unaffected when the cells were treated with clinically relevant dosages of these compounds.
Metabolic processes in animal models differ from humans
"In order to predict the efficacy of Alzheimer drugs, such tests have to be performed directly on the affected human nerve cells", concludes Prof. Brüstle's colleague Dr. Philipp Koch, who led the study. Why do NSAIDs decrease the risk of aggregate formation in animal experiments and cell lines but not in human neurons? The scientists explain this with differences in metabolic processes between these different cell types. "The results are simply not transferable", says Dr. Koch.
The scientists now hope that in the future, testing of potential drugs for the treatment of Alzheimer's disease will be increasingly conducted using neurons obtained from iPS cells of patients. "The development of a single drug takes an average of ten years", says Prof. Brüstle. "By using patient-specific nerve cells as a test system, investments by pharmaceutical companies and the tedious search for urgently needed Alzheimer medications could be greatly streamlined".
INFORMATION:
Publication: APP Processing in Human Pluripotent Stem Cell-Derived Neurons is Resistant to NSAID-Based Gamma-Secretase Modulation, Stem Cell Reports, DOI: 10.1016/j.stemcr.2013.10.011
Contact:
Prof. Dr. Oliver Brüstle
Institute for Reconstructive Neurobiology
Life & Brain Center
University of Bonn
Tel. ++49-228-6885500
E-Mail: r.neuro@uni-bonn.de
Human stem cells predict efficacy of Alzheimer drugs
Researchers from the University of Bonn use reprogrammed patient neurons for drug testing
2013-12-06
ELSE PRESS RELEASES FROM THIS DATE:
New study finds corn oil superior to extra virgin olive oil in lowering cholesterol
2013-12-06
New study finds corn oil superior to extra virgin olive oil in lowering cholesterol
Plant sterols naturally found in corn oil linked to heart health benefits
WASHINGTON, December 6, 2013 – Corn oil significantly reduces cholesterol with more favorable changes ...
Enzalutamide in prostate cancer: Hints of added benefit
2013-12-06
Enzalutamide in prostate cancer: Hints of added benefit
Longer overall survival in patients without visceral metastases / bone complications and pain progression delayed
Enzalutamide (trade name: Xtandi) has been approved since ...
Study finds parental stress linked to obesity in children
2013-12-06
Study finds parental stress linked to obesity in children
Effects on Hispanic children more pronounced
TORONTO, Dec. 6, 2013—Parental stress is linked to weight gain in children, according to a new study from St. Michael's Hospital.
The study found that children ...
What is the link between erectile dysfunction and heart disease?
2013-12-06
What is the link between erectile dysfunction and heart disease?
New Rochelle, NY, December 6, 2013—Erectile dysfunction (ED) is caused by the inability of the artery that supplies blood to the penis to expand and contract properly. The ...
Coal yields plenty of graphene quantum dots
2013-12-06
Coal yields plenty of graphene quantum dots
Rice U. scientists find simple method for producing dots in bulk from coal, coke
HOUSTON – (Dec. 6, 2013) – The prospect of turning coal into fluorescent particles may sound too good to be true, but the possibility exists, thanks ...
Graphene: Growing giants
2013-12-06
Graphene: Growing giants
Huge grains of copper promote better graphene growth
WASHINGTON D.C. Dec. 6, 2013 -- To technology insiders, graphene is a certified big deal. The one-atom thick carbon-based material elicits rhapsodic descriptions as the strongest, ...
1 percent of the population is responsible for 63 percent of violent crime convictions
2013-12-06
1 percent of the population is responsible for 63 percent of violent crime convictions
The majority of all violent crime in Sweden is committed by a small number of people. They are almost all male (92%) who early in life develops violent criminality, substance abuse ...
Frequent cell phone use linked to anxiety, lower grades and reduced happiness in students
2013-12-06
Frequent cell phone use linked to anxiety, lower grades and reduced happiness in students
Today, smartphones are central to college students' lives, keeping them constantly connected with friends, family and the Internet. Students' cell phones are rarely out of reach ...
Taking probiotics in pregnancy or giving them to infants doesn't prevent asthma
2013-12-06
Taking probiotics in pregnancy or giving them to infants doesn't prevent asthma
Taking probiotics has health benefits but preventing childhood asthma isn't one of them, shows newly published research led by medical scientists at the ...
Counting the cost of infertility treatment
2013-12-06
Counting the cost of infertility treatment
From drug therapy to IVF, out-of pocket costs can range from $900 to $19,000 per treatment cycle, report researchers in The Journal of Urology®
New York, NY, December 6, 2013 – Although the demand for infertility treatment ...
LAST 30 PRESS RELEASES:
miRNA dysregulation of AGE/RAGE pathway in metabolic syndrome: a novel analysis strategy utilizing miRNA-profiling data
AI catches one-third of interval breast cancers missed at screening
Researchers advocate for separate roles between AI and humans
SwRI expands antenna testing capabilities with spherical near-field range
The complex relationship between fusion fuel and lithium walls
Study refutes blood thinner brain bleed risk after falls in older adults
"Breakthrough in progeria therapy: RNA scissors precisely target and remove mutant gene"
The Mount Sinai Hospital ranked among top in the nation by US News & World Report®
Storage process: a new method reduces the acute toxicity of the essential oil of Artemisia argyi H. Lév. & Vaniot by 40%
Licensed to live
How to survive the explosion of AI slop
GDF-15 and eGFRdiff: Predicting kidney risk and survival in diabetes mellitus
Detecting cancer cells in blood: the development of microchannel devices with microcone arrays
SLAS Discovery: Advancing tools for cancer fibrosis and drug discovery
Researchers create ‘virtual scientists’ to solve complex biological problems
AI-Powered brain stimulation at home could enhance concentration, new research finds
Carbon-based molecules open new pathways for quantum sensing
Immunotherapy for leukemia may affect the bone marrow environment, cancer researchers find
World’s largest tropical peatlands revealed to be more than 40,000 years old
Pick up the pace of your daily walk to boost longevity, experts say
Normal hormone levels trigger severe depression in some women; researcher discovers mechanism
Mexican neuroscientist identifies glutamate biomarker predicting schizophrenia treatment success
Living brain tissue reveals 80% of genes behave differently than assumed
How much time did our ancestors spend up trees? Studying these chimpanzees might help us find out
Discovery of role of gut hormone in chronic diarrhoea could aid development of new tests and treatments
New discovery reveals the spinal cord’s role in bladder control
Kākāpō decline reveals threat of parasite coextinction
Astrocytes identified as hidden culprit behind PTSD
Offering self-collection kits in routine GP appointments could prevent 1,000 women a year from developing cervical cancer
European study offers clearer picture of childhood brain tumor survival
[Press-News.org] Human stem cells predict efficacy of Alzheimer drugsResearchers from the University of Bonn use reprogrammed patient neurons for drug testing